Journal
New England Journal of Medicine
Publication Date
11-16-2023
Volume
389
Issue
20
First Page
1862
Last Page
1876
Document Type
Open Access Publication
DOI
10.1056/NEJMoa2304430
Rights and Permissions
Bateman RJ, Smith J, Donohue MC, Delmar P, Abbas R, Salloway S, Wojtowicz J, Blennow K, Bittner T, Black SE, Klein G, Boada M, Grimmer T, Tamaoka A, Perry RJ, Turner RS, Watson D, Woodward M, Thanasopoulou A, Lane C, Baudler M, Fox NC, Cummings JL, Fontoura P, Doody RS; GRADUATE I and II Investigators and the Gantenerumab Study Group. Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease. N Engl J Med. 2023 Nov 16;389(20):1862-1876. doi: 10.1056/NEJMoa2304430. Copyright © 2023 Massachusetts Medical Society. Reprinted with permission.
Recommended Citation
Bateman, Randall J and et al., "Two phase 3 trials of gantenerumab in early Alzheimer's disease." New England Journal of Medicine. 389, 20. 1862 - 1876. (2023).
https://digitalcommons.wustl.edu/oa_4/4139
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
